<DOC>
	<DOCNO>NCT01630668</DOCNO>
	<brief_summary>Background : In recent year , probiotic show promise treat variety disease . Previously , investigator report clinical efficacy Lactobacillus reuteri NCIMB 30242 improve lipid profile hypercholesterolemic adult . Objective : The purpose study determine lipid lower efficacy One-a-Day probiotic supplement capsule contain Lactobacillus reuteri NCIMB 30242 12 week subject hypercholesterolemia . Design : The study design double-blinded , placebo-controlled , randomize , parallel-arm , multi-centre study . The study last total 14 week , include 2-week run-in period 12-week intervention period .</brief_summary>
	<brief_title>Efficacy One-a-Day L. Reuteri NCIMB 30242 Probiotic Supplement Capsule</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Inclusion criterion : Males female , age 20 75 year ( bound include ) . LDLC ≥ 3.40 mmol/L ( &lt; 15 % variation visit V0 V21 ) . TG &lt; 4.00 mmol/L ( confirm visit V0 V21 ) . BMI range 23.0 32.5 kg/m2 ( bound include ) . Subject understands accepts follow dietary recommendation advisable hypercholesterolemic patient ( accord NCEPATP III guideline ) . Judged investigator compliant ( &gt; 80 % ) product consumption ( check V21 ) , motivate . Signed informed consent form prior inclusion study . Note : Subjects permit take stable dos thyroid hormone antihypertensive agent , long continue equivalently throughout duration study . If female , subject child bear potential . Defined female hysterectomy oophorectomy , bilateral tubal ligation postmenopausal ( natural surgically &gt; 1 year since last menstruation ) . OR Female subject childbearing potential must agree use medically approve method birth control negative urine pregnancy test result . Acceptable method birth control include : Hormonal contraceptive include oral contraceptive , hormone birth control patch ( Ortho Evra ) , vaginal contraceptive ring ( NuvaRing ) , injectable contraceptive ( DepoProvera , Lunelle ) , hormone implant ( Norplant System ) Intrauterine device Vasectomy partner Total abstinence Exclusion criterion : Use cholesterol lower prescription drug within last 6 month . Use plant sterol , omega 3 , fish oil , soy protein , soluble oat fiber , psyllium seed husk , cholesterol lower nonprescription supplement within last 1 month . History chronic use alcohol ( &gt; 2 drinks/d ) . History heavy smoking ( ≥ 20 cigarettes/d ) . Use systemic antibody , corticosteroid , androgen , phenytoin . Immunecompromised subject ( e.g . AIDS , lymphoma , subject undergoing longterm corticosteroid treatment ) Subject experience cardiovascular event ( Myocardial infarction , coronary artery bypass , major surgical procedure ) last 6 month . Subjects elevate LDLC ( ≥ 3.40 mmol/L ) high ( &gt; 20 % ) CVD risk estimate Framingham risk score . Previously diagnose Type I Type II diabetes . Subject receive systemic treatment topical treatment likely interfere evaluation study parameter . Subject currently involve clinical trial exclusion period follow participation another clinical trial . History angina , congestive heart failure , inflammatory bowel disease , pancreatitis , gastrointestinal , renal , pulmonary , hepatic biliary disease , cancer ( evidence active lesion , chemotherapy surgery past year ) . Clinically significant abnormal laboratory result screen . Chronic user probiotic fibre laxative ( great 2 doses/wk ) , stimulant laxative . History eat disorder . Exercise great 15 miles/wk 4,000 kcal/wk . For female subject : Pregnancy , breast feeding , intent get pregnant . Allergy sensitivity test product ingredient Allergy sensitivity 3 antibiotic ( Clindamycin , Erythromycin Ampicillin ) .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>